The city of Sugar Land, Texas, currently has 1 active clinical trials seeking participants for COPD research studies.
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD
The purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes in the target subject population.
40 years and above
Trial Updated:
Locations: Chiesi Clinical Trial Site 840221, Sugar Land, Texas
Conditions: COPD, COPD Exacerbation